SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
______________
Date of Report (Date of earliest event reported): May 30, 2003
ORCHID BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-30267 | 22-3392819 |
(State or other jurisdiction
of incorporation) | (Commission
File Number) | (IRS Employer
Identification No.) |
| 4390 US ROUTE ONE, PRINCETON, NJ | 08540 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (609) 750-2200
Not Applicable
(Former name or former address, if changed since last report)
Page 1 of 4 pages
Item 5. Other Events.
On May 30, 2003, the Registrant publicly disseminated a press release announcing that the Registrant has realigned its GeneShield business unit. The information contained in the press release is incorporated herein by reference and filed as Exhibit 99.1 hereto.
Item 7. Financial Statements and Exhibits.
| (c) | Exhibits | |
| | | |
| | 99.1 | The Registrant's Press Release dated May 30, 2003. |
Page 2 of 4 pages
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | ORCHID BIOSCIENCES, INC.
(Registrant) |
| Date: May 30, 2003 | | |
| | By: | /s/Andrew P. Savadelis |
| | | Andrew P. Savadelis |
| | | Senior Vice President and Chief Financial
Officer |
| | | |
| | | |
| | | |
Page 3 of 4 pages
EXHIBIT INDEX
Exhibit
Number | Description |
| | |
| 99.1 | The Registrant's Press Release dated May 30, 2003. |
Page 4 of 4 pages
